| GISYX | INSLX | GISYX / INSLX | |
| Total Expense Ratio | 0.90 | 1.08 | 83% |
| Annual Report Gross Expense Ratio | 0.90 | 1.08 | 83% |
| Fund Existence | 11 years | 7 years | - |
| Gain YTD | 20.147 | 1.790 | 1,125% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.34B | 2.42B | 55% |
| Annual Yield % from dividends | 0.65 | 1.76 | 37% |
| Returns for 1 year | 20.23 | -11.74 | -172% |
| Returns for 3 years | 31.37 | -11.17 | -281% |
| Returns for 5 years | -12.62 | -33.25 | 38% |
| Returns for 10 years | 94.56 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPXR | 33.92 | 0.98 | +2.98% |
| Uscf Daily Target 2X Copper Index ETF | |||
| SRLN | 40.40 | 0.03 | +0.07% |
| State Street® Blackstone Senior Loan ETF | |||
| NVBW | 35.60 | 0.01 | +0.04% |
| AllianzIM US Equity Buffer20 Nov ETF | |||
| RTXG | 19.24 | -0.04 | -0.19% |
| Leverage Shares 2X Long Rtx Daily ETF | |||
| LABU | 158.16 | -23.51 | -12.94% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||